Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03092635 · ClinicalTrials.gov registry record · Phase 1
AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy
A Phase 1 study, sponsored by Medical University of South Carolina.
- Terminated
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT03092635 is a Phase 1 study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 9 participants.
The verdict
NCT03092635, a Phase 1 study, was terminated before completion, sponsored by Medical University of South Carolina.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to look at the effects that the study drug (OPC) has on AGE levels in patients with ER+ metastatic breast cancer.
Interventions
- DRUG OPC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-06-06 |
| Est. Completion | 2022-04-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03092635
The ClinicalTrials.gov registry entry for NCT03092635 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OPC is the first listed.
NCT03092635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03092635 about?
NCT03092635 is a clinical study titled "AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy". The purpose of this study is to look at the effects that the study drug (OPC) has on AGE levels in patients with ER+ metastatic breast cancer.
What is the current status of trial NCT03092635?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2017-06-06. Estimated completion is 2022-04-22.
What interventions are being tested in trial NCT03092635?
The interventions under investigation include: OPC (DRUG).
Who is sponsoring clinical trial NCT03092635?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.